Clearside Biomedical, Inc. (CLSDQ) — 8-K Filings

8-K Filings (21)

• 8-K Filing — Dec 29, 2025
• Clearside Biomedical Faces Delisting Notice — Dec 8, 2025 Risk: high
  Clearside Biomedical, Inc. filed an 8-K on December 8, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and a t
• Clearside Biomedical Files 8-K Amid Listing Concerns — Nov 25, 2025 Risk: high
  Clearside Biomedical, Inc. filed an 8-K on November 25, 2025, reporting events as of November 23, 2025. The filing indicates potential issues related to bankrup
• Clearside Biomedical Files 8-K for Other Events — Oct 7, 2025 Risk: medium
  On October 7, 2025, Clearside Biomedical, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure, with no specific deta
• Clearside Biomedical Files 8-K with Corporate Updates — Sep 11, 2025 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on September 10, 2025, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements a
• Clearside Biomedical Changes Fiscal Year End — Sep 11, 2025 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on September 11, 2025, reporting a change in its fiscal year end to December 31. This filing also includes financial sta
• Clearside Biomedical Enters Material Definitive Agreement — Sep 8, 2025 Risk: medium
  Clearside Biomedical, Inc. announced on September 4, 2025, that it entered into a material definitive agreement. The filing does not disclose specific details o
• Clearside Biomedical Files 8-K on Delisting and Shareholder Vote — Sep 3, 2025 Risk: high
  Clearside Biomedical, Inc. filed an 8-K on August 28, 2025, reporting a notice of delisting or failure to satisfy continued listing rules and the submission of
• Clearside Biomedical Faces Delisting Concerns — Aug 14, 2025 Risk: high
  Clearside Biomedical, Inc. filed an 8-K on August 14, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also cove
• Clearside Biomedical Files 8-K on Executive Changes & Costs — Jul 17, 2025 Risk: medium
  On July 17, 2025, Clearside Biomedical, Inc. filed an 8-K report detailing several key events. The company is reporting on cost associated with exit or disposal
• Clearside Biomedical Files 8-K with Corporate Updates — May 30, 2025 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on May 30, 2025, reporting on amendments to its articles of incorporation or bylaws, submission of matters to a vote of
• Clearside Biomedical Files 8-K on Financials — May 14, 2025 Risk: low
  On May 14, 2025, Clearside Biomedical, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as w
• Clearside Biomedical Faces Nasdaq Delisting Warning — Feb 13, 2025 Risk: high
  Clearside Biomedical, Inc. announced on February 7, 2025, that it received a notification from The Nasdaq Stock Market indicating a failure to meet continued li
• Clearside Biomedical Files 8-K — Dec 12, 2024 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on December 12, 2024, to report on various events. The filing includes information related to Regulation FD Disclosure,
• 8-K Filing — Oct 9, 2024
• Clearside Biomedical Files 8-K — Jul 24, 2024 Risk: low
  On July 24, 2024, Clearside Biomedical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No
• Clearside Biomedical Files 8-K on Security Holder Vote — Jun 20, 2024 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on June 20, 2024, to report on the submission of matters to a vote of its security holders. The filing does not contain
• Clearside Biomedical Files 8-K on Operations & Financials — May 9, 2024 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on May 9, 2024, to report on its results of operations and financial condition, as well as to file financial statements
• Clearside Biomedical Files 8-K on Officer/Director Changes — Apr 16, 2024 Risk: low
  Clearside Biomedical, Inc. filed an 8-K on April 16, 2024, reporting on the departure of directors or certain officers, the election of directors, the appointme
• Clearside Biomedical Enters Material Definitive Agreement — Feb 8, 2024 Risk: medium
  Clearside Biomedical, Inc. filed an 8-K on February 8, 2024, reporting an "Entry into a Material Definitive Agreement" on February 6, 2024. This filing indicate
• Clearside Biomedical Enters Material Definitive Agreement — Feb 1, 2024
  Clearside Biomedical, Inc. (CLSD) filed an 8-K on February 1, 2024, reporting an "Entry into a Material Definitive Agreement" on January 31, 2024. This filing i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX